The Incidence and Clinical Features of Anticancer Therapy Induced Atrial Fibrillation in Patients with Breast Cancer Without Previously Established Cardiac Disorder

dc.contributor.authorHunuk, B.
dc.contributor.authorArslan, A.
dc.contributor.authorCagac, O.
dc.contributor.authorOzkaya, O. Gulmez
dc.date.accessioned2023-09-15T13:05:03Z
dc.date.available2023-09-15T13:05:03Z
dc.date.issued2022
dc.identifier.eissn1522-9645en_US
dc.identifier.endpage542en_US
dc.identifier.issn0195-668Xen_US
dc.identifier.issueSupplement 2en_US
dc.identifier.startpage542en_US
dc.identifier.urihttp://hdl.handle.net/11727/10679
dc.identifier.volume43en_US
dc.identifier.wos000894947902641en_US
dc.language.isoengen_US
dc.relation.journalEUROPEAN HEART JOURNALen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe Incidence and Clinical Features of Anticancer Therapy Induced Atrial Fibrillation in Patients with Breast Cancer Without Previously Established Cardiac Disorderen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: